Company Filing History:
Years Active: 1999
Title: The Innovations of Steven L. Porter
Introduction
Steven L. Porter is a notable inventor based in Redwood City, California. He has made significant contributions to the field of medicine, particularly in the treatment of viral infections. His work has led to the development of innovative therapies that aim to improve patient outcomes.
Latest Patents
Porter holds a patent for the treatment of hepatitis B infection using thymosin alpha 1 and famciclovir. This patent outlines a drug regimen that includes an antiviral-effective amount of thymosin alpha 1 (T.alpha.1) and famciclovir to effectively combat hepatitis B virus (HBV) infection in patients. This innovative approach showcases his commitment to advancing medical treatments.
Career Highlights
Steven L. Porter is currently associated with SciClone Pharmaceuticals, Inc., where he continues to work on developing effective therapies for various viral infections. His expertise and dedication to research have positioned him as a valuable asset in the pharmaceutical industry.
Collaborations
Porter has collaborated with various professionals in the field, including his coworker David A. Karlin. These collaborations have fostered an environment of innovation and have contributed to the advancement of medical treatments.
Conclusion
Steven L. Porter is a distinguished inventor whose work in the treatment of hepatitis B has made a significant impact in the medical field. His innovative approaches and collaborations continue to pave the way for advancements in antiviral therapies.